Literature DB >> 24600034

Tissue-specific microvascular endothelial cells show distinct capacity to activate NK cells: implications for the pathophysiology of granulomatosis with polyangiitis.

Sara Tognarelli1, Julie Gayet, Marion Lambert, Stéphanie Dupuy, Alexandre Karras, Pascal Cohen, Loïc Guillevin, Mathilde de Menthon, Sophie Caillat-Zucman.   

Abstract

The relevance of tissue specificity of microvascular endothelial cells (MECs) in the response to inflammatory stimuli and sensitivity to immune cell-mediated injury is not well defined. We hypothesized that such MEC characteristics might shape their interaction with NK cells through the use of different adhesion molecules and NK cell receptor ligands or the release of different soluble factors and render them more or less vulnerable to NK cell injury during autoimmune vasculitis, such as granulomatosis with polyangiitis (GPA). To generate a comprehensive expression profile of human MECs of renal, lung, and dermal tissue origin, we characterized, in detail, their response to inflammatory cytokines and to proteinase 3, a major autoantigen in GPA, and analyzed the effects on NK cell activation. In this study, we show that renal MECs were more susceptible than lung and dermal MECs to the effect of inflammatory signals, showing upregulation of ICAM-1 and VCAM-1 on their surface, as well as release of CCL2, soluble fractalkine, and soluble VCAM-1. Proteinase 3-stimulated renal and lung MECs triggered CD107a degranulation in control NK cell. Notably, NK cells from GPA patients expressed markers of recent in vivo activation (CD69, CD107a), degranulated more efficiently than did control NK cells in the presence of renal MECs, and induced direct killing of renal MECs in vitro. These results suggest that, upon inflammatory conditions in GPA, renal MECs may contribute to the recruitment and activation of NK cells in the target vessel wall, which may participate in the necrotizing vasculitis of the kidney during this disease.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24600034     DOI: 10.4049/jimmunol.1301508

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

Review 1.  Innate immune cells in the pathogenesis of primary systemic vasculitis.

Authors:  Durga Prasanna Misra; Vikas Agarwal
Journal:  Rheumatol Int       Date:  2015-09-24       Impact factor: 2.631

2.  In situ evidence of pulmonary endothelial activation in patients with granulomatosis with polyangiitis and systemic sclerosis.

Authors:  Leticia Kawano-Dourado; Alexandre M Ab'Saber; Vera Luiza Capelozzi; Carla Valeri; Carmen Sílvia Valente Barbas
Journal:  Lung       Date:  2015-03-19       Impact factor: 2.584

Review 3.  Concise review: tissue-specific microvascular endothelial cells derived from human pluripotent stem cells.

Authors:  Hannah K Wilson; Scott G Canfield; Eric V Shusta; Sean P Palecek
Journal:  Stem Cells       Date:  2014-12       Impact factor: 6.277

4.  Homing receptor expression is deviated on CD56+ blood lymphocytes during pregnancy in Type 1 diabetic women.

Authors:  Suzanne D Burke; Alexandra V C Seaward; Heather Ramshaw; Graeme N Smith; Sophia Virani; Barbara A Croy; Patricia D A Lima
Journal:  PLoS One       Date:  2015-03-20       Impact factor: 3.240

5.  IFNγ, and to a Lesser Extent TNFα, Provokes a Sustained Endothelial Costimulatory Phenotype.

Authors:  Nicole M Valenzuela
Journal:  Front Immunol       Date:  2021-04-15       Impact factor: 7.561

6.  Peripheral blood natural killer cell percentages in granulomatosis with polyangiitis correlate with disease inactivity and stage.

Authors:  Wolfgang Merkt; Prisca Sturm; Felix Lasitschka; Theresa Tretter; Carsten Watzl; Daniel Saure; Michael Hundemer; Vedat Schwenger; Norbert Blank; Hanns-Martin Lorenz; Adelheid Cerwenka
Journal:  Arthritis Res Ther       Date:  2015-11-21       Impact factor: 5.156

7.  Active but not inactive granulomatosis with polyangiitis is associated with decreased and phenotypically and functionally altered CD56(dim) natural killer cells.

Authors:  Wolfgang Merkt; Maren Claus; Norbert Blank; Michael Hundemer; Adelheid Cerwenka; Hanns-Martin Lorenz; Carsten Watzl
Journal:  Arthritis Res Ther       Date:  2016-09-13       Impact factor: 5.156

8.  Natural Killer Cells Exhibit a Peculiar Phenotypic Profile in Systemic Sclerosis and Are Potent Inducers of Endothelial Microparticles Release.

Authors:  Audrey Benyamine; Jérémy Magalon; Florence Sabatier; Luc Lyonnet; Stéphane Robert; Chloé Dumoulin; Sophie Morange; Karin Mazodier; Gilles Kaplanski; Martine Reynaud-Gaubert; Pascal Rossi; Françoise Dignat-George; Brigitte Granel; Pascale Paul
Journal:  Front Immunol       Date:  2018-07-18       Impact factor: 7.561

Review 9.  Natural Killer Cells in Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - A Review of the Literature.

Authors:  Sina Fuchs; Andrea Scheffschick; Iva Gunnarsson; Hanna Brauner
Journal:  Front Immunol       Date:  2022-01-14       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.